Publications by authors named "Axel Muendlein"

Claim this Profile
L
Leucine-rich α-2 glycoprotein 1 is associated with increased mortality risk in patients with peripheral artery disease.
Axel Muendlein, Andreas Leiherer, Eva Maria Brandtner, Christine Heinzle, Kathrin Geiger

J Mol Med (Berl)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiopoietin-like protein 2 and mortality in patients with heart failure-Results from an observational study.
Eva Maria Brandtner, Andreas Leiherer, Barbara Larcher, Kathrin Geiger, Christine Heinzle, Axel Muendlein

Eur J Clin Invest· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistent Hypercalcemia Despite Parathyroidectomy for Primary Hyperparathyroidism in an Adult with Nephrocalcinosis and Nephrolithiasis Caused by a Novel Combination of Two Pathogenic Mutations.
Sijun Zhang, Axel Muendlein, Edgar Meusburger, Emanuel Zitt

Int J Mol Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum leucine-rich α-2 glycoprotein 1 predicts 10-year mortality and vascular events in coronary angiography patients.
Axel Muendlein, Andreas Leiherer, Eva Maria Brandtner, Kathrin Geiger, Christine Heinzle

Atherosclerosis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Data on the Efficacy of Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma and Amplification 1q.
Magdalena Benda, Patrick Reimann, Elena Bletzacher, Axel Muendlein, Benda Bernhard

Cancers (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Circulating Glypican-4 in Patients with ESKD.
Axel Muendlein, Eva Maria Brandtner, Judith Schimpf, Michael Piribauer, Kathrin Geiger

Kidney360· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three decades of glucose-lowering therapy in patients at high cardiovascular risk - A real-world analysis.
Magdalena Neyer, Johannes B Vogel, Pascal Elsner, Heike Kuehrer, Christoph H Saely, Axel Muendlein

Diabetes Obes Metab· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine Learning Approach to Metabolomic Data Predicts Type 2 Diabetes Mellitus Incidence.
Andreas Leiherer, Axel Muendlein, Sylvia Mink, Arthur Mader, Christoph H Saely

Int J Mol Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The value of earlier-in-life systolic and diastolic blood pressure for cardiovascular risk prediction.
Andreas Leiherer, Wolfgang Brozek, Axel Muendlein, Hanno Ulmer, Christoph H Saely

iScience· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ceramides improve cardiovascular risk prediction beyond low-density lipoprotein cholesterol.
Andreas Leiherer, Axel Muendlein, Christoph H Saely, Reijo Laaksonen, Peter Fraunberger

Eur Heart J Open· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myricetin attenuates hypoxia-induced inflammation in human adipocytes.
Kathrin Geiger, Axel Muendlein, Andreas Leiherer, Stella Gaenger, Eva Maria Brandtner

Mol Biol Rep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating glypican-4 is a new predictor of all-cause mortality in patients with heart failure.
Axel Muendlein, Christine Heinzle, Andreas Leiherer, Eva Maria Brandtner, Kathrin Geiger

Clin Biochem· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma apolipoprotein M predicts overall survival in metastatic breast cancer patients.
Axel Muendlein, Christine Heinzle, Eva Maria Brandtner, Andreas Leiherer, Kathrin Geiger

Breast Cancer Res Treat· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The optimal healthy ranges of thyroid function defined by the risk of cardiovascular disease and mortality: systematic review and individual participant data meta-analysis.
Yanning Xu, Arash Derakhshan, Ola Hysaj, Lea Wildisen, Till Ittermann, Axel Muendlein

Lancet Diabetes Endocrinol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary Event Risk Test (CERT) as a Risk Predictor for the 10-Year Clinical Outcome of Patients with Peripheral Artery Disease.
Andreas Leiherer, Axel Muendlein, Christoph H Saely, Kathrin Geiger, Eva-Maria Brandtner

J Clin Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-free circulating RAS mutation concentrations significantly impact the survival of metastatic colorectal cancer patients.
Axel Muendlein, Kathrin Geiger, Christine Heinzle, Stella Gaenger, Thomas Winder

J Cancer Res Clin Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Glypican-4 Is a Predictor of 24-Month Overall Survival in Metastatic Breast Cancer.
Axel Muendlein, Christine Heinzle, Eva Maria Brandtner, Andreas Leiherer, Heinz Drexel

Oncol Res Treat· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum glypican-4 is associated with the 10-year clinical outcome of patients with peripheral artery disease.
Axel Muendlein, Christine Heinzle, Andreas Leiherer, Kathrin Geiger, Eva Maria Brandtner

Int J Cardiol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating syndecan-1 and glypican-4 predict 12-month survival in metastatic colorectal cancer patients.
Axel Muendlein, Luciano Severgnini, Thomas Decker, Christine Heinzle, Andreas Leiherer

Front Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data on the association of serum glypican-4 with future major adverse cardiovascular events and mortality in patients undergoing coronary angiography.
Axel Muendlein, Eva Maria Brandtner, Andreas Leiherer, Kathrin Geiger, Christine Heinzle

Data Brief· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the association of serum glypican-4 with prevalent and future kidney function.
Axel Muendlein, Eva Maria Brandtner, Andreas Leiherer, Kathrin Geiger, Christine Heinzle

Sci Rep· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Volatilomic Signatures of AGS and SNU-1 Gastric Cancer Cell Lines.
Daria Ślefarska-Wolak, Christine Heinzle, Andreas Leiherer, Clemens Ager, Axel Muendlein

Molecules· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal Evolution in Patients with Hormone Receptor Positive, HER-2 Negative Breast Cancer Treated with Chemotherapy or CDK4/6 Inhibitors.
Thomas Decker, Matthias Bichler, Andrea Birtel, Gerhard Fischer, Kathrin Geiger, Axel Muendlein

Oncol Res Treat· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 RBD-specific and NP-specific antibody response of healthcare workers in the westernmost Austrian state Vorarlberg: a prospective cohort study.
Michele Atzl, Axel Muendlein, Thomas Winder, Peter Fraunberger, Eva-Maria Brandtner

BMJ Open· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum glypican-4 is a marker of future vascular risk and mortality in coronary angiography patients.
Axel Muendlein, Eva Maria Brandtner, Andreas Leiherer, Kathrin Geiger, Christine Heinzle

Atherosclerosis· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis